Goretzki P E, West M, Koob R, Koller C, Joseph K, Röher H D
Acta Endocrinol Suppl (Copenh). 1987;281:281-7. doi: 10.1530/acta.0.114s281.
Primary cell cultures of normal and adenomatous human thyroid tissues were incubated with TSH or ammonium sulphate precipited IGG fractions (1 mg/ml) of sera from patients with different thyroid diseases (Graves' disease: active n = 7 in remission n = 12; thyroid autonomy n = 39; simple euthyroid goitre n = 15) and were compared to controls (n = 26). [3H]thymidine incorporation in primary thyrocyte cultures demonstrated a typical bell shape curve after incubation with EGF and TSH with a maximal effect at 10-100 microIU/ml. This effect, however, was inconsistent and positive only in 2 of 7 primary cultures. Only TSH positive cultures were used for IgG studies. 16-28% of IGG fractions from sera of thyroid patients caused high (more than X + 5 SD of controls) stimulation of [3H]thymidine incorporation. Dose response curves of IgG fractions of 19 additional patients (Graves' disease in remission n = 15; thyroid autonomy n = 4) showed an increase in [3H]thymidine incorporation at 0.1 mg protein/ml for 10 patients and at low concentrations of 10-5 mg/ml for 5 patients. There was a good correlation (r = 0.72) (P less than 0.0001) between positive findings in TSH-binding inhibition (TBII) and AC-stimulation (TSI) IGG fractions but none between stimulation of [3H]thymidine incorporation and any other thyroid specific immunoglobulin nor thyroid function nor any other available data. Immunoglobulins stimulating [3H]thymidine incorporation differ therefore from TBII and TSI. The growth effect of these immunoglobulins, however, has yet to be determined.
将正常和腺瘤性人类甲状腺组织的原代细胞培养物与促甲状腺激素(TSH)或来自不同甲状腺疾病患者(格雷夫斯病:活动期n = 7,缓解期n = 12;甲状腺自主性n = 39;单纯甲状腺肿n = 15)血清的硫酸铵沉淀免疫球蛋白G(IgG)组分(1mg/ml)一起孵育,并与对照组(n = 26)进行比较。原代甲状腺细胞培养物中[3H]胸腺嘧啶核苷掺入在与表皮生长因子(EGF)和TSH孵育后呈现典型的钟形曲线,在10 - 100微国际单位/毫升时具有最大效应。然而,这种效应并不一致,仅在7个原代培养物中的2个中呈阳性。仅将TSH阳性培养物用于IgG研究。来自甲状腺疾病患者血清的IgG组分中,16 - 28%导致[3H]胸腺嘧啶核苷掺入的高度刺激(超过对照组的X + 5标准差)。另外19名患者(格雷夫斯病缓解期n = 15;甲状腺自主性n = 4)的IgG组分的剂量反应曲线显示,10名患者在0.1mg蛋白/毫升时[3H]胸腺嘧啶核苷掺入增加,5名患者在10 - 5mg/ml的低浓度时增加。促甲状腺激素结合抑制(TBII)和促肾上腺皮质激素刺激(TSI)IgG组分的阳性结果之间存在良好的相关性(r = 0.72)(P < 0.0001),但[3H]胸腺嘧啶核苷掺入的刺激与任何其他甲状腺特异性免疫球蛋白、甲状腺功能或任何其他可用数据之间均无相关性。因此,刺激[3H]胸腺嘧啶核苷掺入的免疫球蛋白不同于TBII和TSI。然而,这些免疫球蛋白的生长效应尚未确定。